Press Release

Indonesia Over the Counter (OTC) Drugs Market to be dominated by Analgesics through 2028

Increase in chronic diseases is expected to drive the growth of Indonesia Over the Counter (OTC) Drugs Market in the forecast period, 2024-2028

 

According to TechSci Research report, “Indonesia Over the Counter (OTC) Drugs Market - By Region, Competition Forecast and Opportunities, 2018-2028, the Indonesia Over the Counter (OTC) Drugs Market is anticipated to grow at an impressive rate in the forecast period of 2024-2028. This can be attributed to the increase in use of gastrointestinal drugs. Gastrointestinal issues, such as indigestion, acid reflux, stomach discomfort, and gastrointestinal infections, are prevalent among the Indonesian population. The adoption of modern lifestyles, including sedentary habits and changes in dietary patterns, has led to an increase in gastrointestinal issues. Consuming spicy or fatty foods, irregular mealtimes, and a lack of dietary fiber can contribute to digestive problems, resulting in higher demand for gastrointestinal drugs. Pharmaceutical companies and healthcare providers often engage in marketing and promotional activities to raise awareness about gastrointestinal disorders and the available treatment options. These efforts contribute to increased consumer knowledge and the recognition of gastrointestinal drugs as viable solutions for managing related health issues. Many gastrointestinal drugs, such as antacids, antidiarrheals, and laxatives, are available over the counter in pharmacies and retail outlets. This accessibility allows consumers to obtain these medications without a prescription, leading to an increase in self-medication practices for managing gastrointestinal symptoms.

A major trend in the market is the focus on sustainable and environmentally friendly practices. Consumers and stakeholders are increasingly concerned about the environmental impact of products and are seeking sustainable alternatives. There is a growing emphasis on reducing packaging waste and promoting eco-friendly packaging in the OTC drugs market. Companies are exploring sustainable packaging materials, such as biodegradable or recyclable materials, and optimizing packaging sizes to minimize waste. Additionally, initiatives like refillable packaging and bulk options are gaining traction. Proper disposal of expired or unused OTC drugs is gaining attention. There is an increasing focus on educating consumers about the appropriate disposal methods to prevent environmental contamination. Some pharmacies and healthcare facilities offer take-back programs or facilitate the proper disposal of unused medications. Certifications and standards related to sustainability and environmental practices are becoming more relevant in the Indonesian OTC drugs market. Companies that adhere to recognized standards, such as organic certifications or sustainable sourcing certifications, can gain a competitive edge and build consumer trust.

A challenge faced by the Indonesia Over the Counter (OTC) Drugs Market is counterfeit products. Counterfeit OTC drugs refer to products that may contain incorrect ingredients, incorrect dosages, or harmful substances. Consuming such products can pose serious health risks to consumers, as they may not provide the intended therapeutic effects or may cause adverse reactions and complications. Counterfeit products are intentionally misrepresented, typically in terms of their identity, source, or composition. They can negatively impact the reputation and trustworthiness of legitimate OTC drug brands. When consumers unknowingly purchase counterfeit products that do not deliver the expected results, it can erode their trust in the brand and undermine their confidence in the OTC drugs.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Indonesia Over the Counter (OTC) Drugs Market.

 

 

The Indonesia Over the Counter (OTC) Drugs Market can be segmented by Product Type, by Route of Administration, by Dosage Form, by Distribution Channel, by End User, and by region. Based on Route of Administration, the Indonesia Over the Counter (OTC) Drugs Market can be segmented into Oral, Topical, and Parenteral. The parenteral route of administration refers to the administration of drugs directly into the body through non-oral routes, bypassing the gastrointestinal tract. It involves injecting the drug into the body using various methods such as intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes. The parenteral route of administration offers several advantages, including rapid onset of action, bypassing gastrointestinal degradation, and greater bioavailability compared to oral administration. It is often used when the drug's characteristics or the patient's condition necessitate direct delivery into the bloodstream or muscle tissue.

Based on Distribution Channel, the Indonesia Over the Counter (OTC) Drugs Market can be segmented into Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy. Indonesia has experienced a significant increase in internet penetration and smartphone usage, leading to the growth of e-commerce in various sectors, including healthcare. The convenience and accessibility of online shopping have led to the rise of e-pharmacies, allowing consumers to order OTC drugs and healthcare products from the comfort of their homes. E-pharmacies in Indonesia offer a wide range of OTC drugs and healthcare products. Consumers can browse through a vast selection of products, compare prices, read product descriptions, and make informed purchasing decisions.

 

Major companies operating in Indonesia Over the Counter (OTC) Drugs Market are:

  • PT Kalbe Farma Tbk
  • PT Kimia Farma Tbk
  • PT Tempo Scan Pacific Tbk
  • PT Sanbe Farma
  • PT Phapros Tbk
  • Johnson & Johnson Indonesia PT
  • GlaxoSmithKline Indonesia PT
  • PT. Bayer Indonesia


In 2022, PT Kalbe Farma Tbk or Kalbe, through its subsidiary PT Forsta Kalmedic Worldwide (Forsta), held a seminar as a concern for the medical device industry, aimed at promoting public accessibility and flexibility in the sector.

In 2022, PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Bifarma Adiluhung, introduced the genetic testing services in Indonesia, known as KiddyGENME and PrimeGENME.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“Indonesia Over the Counter (OTC) Drugs Market is expected to grow during the forecast period due to the growing demand for eco-friendly manufacturing. OTC drug manufacturers in Indonesia are adopting eco-friendly manufacturing processes to reduce energy consumption, water usage, and waste generation. By implementing sustainable manufacturing practices, such as energy-efficient technologies and recycling programs, they are able to minimize the environmental footprint of the production process and gain consumer trust. Additionally, the increasing concerns regarding health and rising expenditure on health and wellness are expected to create lucrative opportunities for market growth," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

Indonesia Over The Counter Drugs Market  By Product Type (Cough, Cold and Flu, Vitamins, Mineral, and Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others),             By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquid & Solutions, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By End User (Adults, Geriatric, Pregnant Females, Children, Infants), By Region, Competition Forecast & Opportunities, 2018-2028F, has evaluated the future growth potential of Indonesia Over the Counter (OTC) Drugs Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Indonesia Over the Counter (OTC) Drugs Market.

 

Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: https://www.techsciresearch.com               

Relevant News